1 2 3 4 UNITED STATES DISTRICT COURT 5 DISTRICT OF NEVADA 6 * * *
7 THE AVID GROUP, LLC, Case No.2:24-CV-1470 JCM (NJK)
8 Plaintiff(s), ORDER 9 v.
10 ARIXA ANIMAL DIAGNOSTICS, INC., et al.,
11 Defendant(s).
12 13 Presently before the court is plaintiff and counter defendant The AViD Group, LLC’s 14 (“AViD”) motion to dismiss counterclaims. (ECF No. 33). Defendant and counterclaimant Arixa 15 Animal Diagnostics, Inc. (“Arixa”) responded in opposition (ECF No. 37) to which AViD replied 16 (ECF No. 41). 17 I. BACKGROUND 18 19 AViD now moves to dismiss Arixa’s four counterclaims under Rule 12(b)(6) for failure to 20 state a claim. (ECF No. 33 at 2). The countercomplaint asserts breach of contract, breach of the 21 implied covenant of good faith and fair dealing, promissory estoppel, and unjust enrichment. (ECF 22 No. 27 at 26-30). 23 On December 23, 2021, AViD and Arixa entered into a letter agreement to develop and 24 25 commercialize a series of veterinary diagnostic devices. (ECF No. 33 at 2). Both parties agreed 26 to a budget plan that obligated AViD to fund $1,500,000 to Arixa and to favorably consider 27 providing funding to Arixa for potential overages of approximately $400,000. (Id. at 3). The 28 agreement also contained an integration clause and required that any modifications be made in 1 writing and signed by both parties. (Id. at 4). 2 Arixa alleges AViD failed to fulfill its funding obligations. (ECF No. 27 at 26). Arixa 3 further alleges that Mr. Baum, the president and founder of AViD, failed to fulfill additional 4 promises made to it. (Id. at 28). 5 6 II. LEGAL STANDARD 7 Federal Rule of Civil Procedure 8 requires every pleading to contain a 8 “short and plain statement of the claim showing that the pleader is entitled to relief.” Fed. R. Civ. 9 P. 8. Although Rule 8 does not require detailed factual allegations, it does require more than 10 “labels and conclusions” or a “formulaic recitation of the elements of a cause of action.” Ashcroft 11 12 v. Iqbal, 556 U.S. 662, 678 (2009) (citation omitted). In other words, a pleading must have 13 plausible factual allegations that cover “all the material elements necessary to sustain recovery 14 under some viable legal theory.” Bell Atl. Corp. v. Twombly, 550 U.S. 544, 562 (2007) (citation 15 omitted) (emphasis in original); see also Mendiondo v. Centinela Hosp. Med. Ctr., 521 F.3d 1097, 16 1104 (9th Cir. 2008). 17 18 The Supreme Court in Iqbal clarified the two-step approach to evaluate a complaint’s legal 19 sufficiency on a Rule 12(b)(6) motion to dismiss. First, the court must accept as true all well- 20 pleaded factual allegations and draw all reasonable inferences in the plaintiff’s favor. Iqbal, 556 21 U.S. at 678–79. Legal conclusions are not entitled to this assumption of truth. Id. Second, the 22 court must consider whether the well-pleaded factual allegations state a plausible claim for relief. 23 24 Id. at 679. A claim is facially plausible when the court can draw a reasonable inference that the 25 defendant is liable for the alleged misconduct. Id. at 678. When the allegations have not crossed 26 the line from conceivable to plausible, the complaint must be dismissed. Twombly, 550 U.S. at 27 570; see also Starr v. Baca, 652 F.3d 1202, 1216 (9th Cir. 2011). 28 1 If the court grants a Rule 12(b)(6) motion to dismiss, it should grant leave to amend unless 2 the deficiencies cannot be cured by amendment. DeSoto v. Yellow Freight Sys., Inc., 957 F.2d 3 655, 658 (9th Cir. 1992). Under Rule 15(a), the court should “freely” grant leave to amend “when 4 justice so requires,” and absent “undue delay, bad faith or dilatory motive on the part of the movant, 5 6 repeated failure to cure deficiencies by amendments . . . undue prejudice to the opposing 7 party . . . futility of the amendment, etc.” Foman v. Davis, 371 U.S. 178, 182 (1962). The court 8 should grant leave to amend “even if no request to amend the pleading was made.” Lopez v. Smith, 9 203 F.3d 1122, 1127 (9th Cir. 2000) (en banc) (internal quotation marks omitted). 10 The futility of amendment is a recognized exception to the general rule of granting leave 11 12 to amend. If the court finds that amending certain claims would not cure the deficiencies in the 13 pleading, it may deny leave to amend those claims while allowing amendment of others that could 14 potentially be remedied. Hubbard v. SEIU Local 2015, 552 F.Supp.3d 955, 962 (2021). 15 III. DISCUSSION 16 The parties do not dispute that Delaware law applies to both breach claims because a choice 17 18 of law provision exists within the agreement. (ECF No. 37 at 4,7). Under the rule of dépeçage, 19 Delaware law governs Arixa’s promissory estoppel counterclaim, which neither party disputes. 20 (ECF No. 33 at 13-14). 21 Both parties agree that Nevada law governs Arixa’s unjust enrichment counterclaim, as 22 Nevada has the most significant relationship to the claim when analyzed under Restatement 23 24 (Second) of Conflict of Laws § 221. See Casun Inv., A.G. v. Ponder, 119 F.4th 637, 645 (9th Cir. 25 2024) (“Nevada tends to follow the Restatement (Second) of Conflict of Laws (1971) in 26 determining choice-of-law questions involving contracts, and unjust enrichment is a quasi- 27 contractual claim in Nevada.”). 28 1 A. Breach of Contract. 2 “Under Delaware law, the elements of a breach of contract claim are: 1) a contractual 3 obligation; 2) a breach of that obligation by the defendant; and 3) a resulting damage to the 4 plaintiff.” Cedarview Opportunities Master Fund, L.P. v. Spanish Broad. Sys., 2018 Del. Ch. 5 6 LEXIS 292, at *15 (Del. Ch. August 27, 2018) (citation omitted). AViD claims the breach of 7 contract counterclaim fails because (1) Arixa fails to identify which provision of the agreement 8 AViD allegedly breached, and (2) Arixa’s own admissions in its amended answer confirm that 9 AViD did not breach the agreement. (ECF No. 33 at 7). The court is not convinced. 10 Here, a valid contract exists between AViD and Arixa in which AViD was obligated to 11 12 provide funding in exchange for product development. The court can ascertain two separate 13 provisions as components of AViD’s “funding obligation,” (1) the obligation to fund $1,500,000 14 and (2) the obligation to “favorably consider” funding overages that may exceed the funding 15 budget of approximately $400,000. The first obligation is not in dispute, as Arixa acknowledges 16 in its amended answer that AViD paid the amount in full. (ECF No. 27 at 19). 17 18 Arixa alleges that AViD halted payments pursuant to the contract and “failed to honor” its 19 funding obligations which caused Arixa financial problems. (ECF No. 27 at 28). At the pleading 20 stage, these allegations are sufficient to support a plausible claim for relief for breach of contract. 21 Whether AViD acted within its contractual rights in using discretion in funding overages is a 22 factual issue not appropriate for resolution on a 12(b)(6) motion. Arixa’s breach of contract claim 23 24 therefore survives dismissal. 25 B. Breach of the Implied Covenant of Good Faith and Fair Dealing. 26 Under Delaware law, every contract contains an implied covenant of good faith and fair 27 dealing. Dunlap v. State Farm Fire & Cas.
Free access — add to your briefcase to read the full text and ask questions with AI
1 2 3 4 UNITED STATES DISTRICT COURT 5 DISTRICT OF NEVADA 6 * * *
7 THE AVID GROUP, LLC, Case No.2:24-CV-1470 JCM (NJK)
8 Plaintiff(s), ORDER 9 v.
10 ARIXA ANIMAL DIAGNOSTICS, INC., et al.,
11 Defendant(s).
12 13 Presently before the court is plaintiff and counter defendant The AViD Group, LLC’s 14 (“AViD”) motion to dismiss counterclaims. (ECF No. 33). Defendant and counterclaimant Arixa 15 Animal Diagnostics, Inc. (“Arixa”) responded in opposition (ECF No. 37) to which AViD replied 16 (ECF No. 41). 17 I. BACKGROUND 18 19 AViD now moves to dismiss Arixa’s four counterclaims under Rule 12(b)(6) for failure to 20 state a claim. (ECF No. 33 at 2). The countercomplaint asserts breach of contract, breach of the 21 implied covenant of good faith and fair dealing, promissory estoppel, and unjust enrichment. (ECF 22 No. 27 at 26-30). 23 On December 23, 2021, AViD and Arixa entered into a letter agreement to develop and 24 25 commercialize a series of veterinary diagnostic devices. (ECF No. 33 at 2). Both parties agreed 26 to a budget plan that obligated AViD to fund $1,500,000 to Arixa and to favorably consider 27 providing funding to Arixa for potential overages of approximately $400,000. (Id. at 3). The 28 agreement also contained an integration clause and required that any modifications be made in 1 writing and signed by both parties. (Id. at 4). 2 Arixa alleges AViD failed to fulfill its funding obligations. (ECF No. 27 at 26). Arixa 3 further alleges that Mr. Baum, the president and founder of AViD, failed to fulfill additional 4 promises made to it. (Id. at 28). 5 6 II. LEGAL STANDARD 7 Federal Rule of Civil Procedure 8 requires every pleading to contain a 8 “short and plain statement of the claim showing that the pleader is entitled to relief.” Fed. R. Civ. 9 P. 8. Although Rule 8 does not require detailed factual allegations, it does require more than 10 “labels and conclusions” or a “formulaic recitation of the elements of a cause of action.” Ashcroft 11 12 v. Iqbal, 556 U.S. 662, 678 (2009) (citation omitted). In other words, a pleading must have 13 plausible factual allegations that cover “all the material elements necessary to sustain recovery 14 under some viable legal theory.” Bell Atl. Corp. v. Twombly, 550 U.S. 544, 562 (2007) (citation 15 omitted) (emphasis in original); see also Mendiondo v. Centinela Hosp. Med. Ctr., 521 F.3d 1097, 16 1104 (9th Cir. 2008). 17 18 The Supreme Court in Iqbal clarified the two-step approach to evaluate a complaint’s legal 19 sufficiency on a Rule 12(b)(6) motion to dismiss. First, the court must accept as true all well- 20 pleaded factual allegations and draw all reasonable inferences in the plaintiff’s favor. Iqbal, 556 21 U.S. at 678–79. Legal conclusions are not entitled to this assumption of truth. Id. Second, the 22 court must consider whether the well-pleaded factual allegations state a plausible claim for relief. 23 24 Id. at 679. A claim is facially plausible when the court can draw a reasonable inference that the 25 defendant is liable for the alleged misconduct. Id. at 678. When the allegations have not crossed 26 the line from conceivable to plausible, the complaint must be dismissed. Twombly, 550 U.S. at 27 570; see also Starr v. Baca, 652 F.3d 1202, 1216 (9th Cir. 2011). 28 1 If the court grants a Rule 12(b)(6) motion to dismiss, it should grant leave to amend unless 2 the deficiencies cannot be cured by amendment. DeSoto v. Yellow Freight Sys., Inc., 957 F.2d 3 655, 658 (9th Cir. 1992). Under Rule 15(a), the court should “freely” grant leave to amend “when 4 justice so requires,” and absent “undue delay, bad faith or dilatory motive on the part of the movant, 5 6 repeated failure to cure deficiencies by amendments . . . undue prejudice to the opposing 7 party . . . futility of the amendment, etc.” Foman v. Davis, 371 U.S. 178, 182 (1962). The court 8 should grant leave to amend “even if no request to amend the pleading was made.” Lopez v. Smith, 9 203 F.3d 1122, 1127 (9th Cir. 2000) (en banc) (internal quotation marks omitted). 10 The futility of amendment is a recognized exception to the general rule of granting leave 11 12 to amend. If the court finds that amending certain claims would not cure the deficiencies in the 13 pleading, it may deny leave to amend those claims while allowing amendment of others that could 14 potentially be remedied. Hubbard v. SEIU Local 2015, 552 F.Supp.3d 955, 962 (2021). 15 III. DISCUSSION 16 The parties do not dispute that Delaware law applies to both breach claims because a choice 17 18 of law provision exists within the agreement. (ECF No. 37 at 4,7). Under the rule of dépeçage, 19 Delaware law governs Arixa’s promissory estoppel counterclaim, which neither party disputes. 20 (ECF No. 33 at 13-14). 21 Both parties agree that Nevada law governs Arixa’s unjust enrichment counterclaim, as 22 Nevada has the most significant relationship to the claim when analyzed under Restatement 23 24 (Second) of Conflict of Laws § 221. See Casun Inv., A.G. v. Ponder, 119 F.4th 637, 645 (9th Cir. 25 2024) (“Nevada tends to follow the Restatement (Second) of Conflict of Laws (1971) in 26 determining choice-of-law questions involving contracts, and unjust enrichment is a quasi- 27 contractual claim in Nevada.”). 28 1 A. Breach of Contract. 2 “Under Delaware law, the elements of a breach of contract claim are: 1) a contractual 3 obligation; 2) a breach of that obligation by the defendant; and 3) a resulting damage to the 4 plaintiff.” Cedarview Opportunities Master Fund, L.P. v. Spanish Broad. Sys., 2018 Del. Ch. 5 6 LEXIS 292, at *15 (Del. Ch. August 27, 2018) (citation omitted). AViD claims the breach of 7 contract counterclaim fails because (1) Arixa fails to identify which provision of the agreement 8 AViD allegedly breached, and (2) Arixa’s own admissions in its amended answer confirm that 9 AViD did not breach the agreement. (ECF No. 33 at 7). The court is not convinced. 10 Here, a valid contract exists between AViD and Arixa in which AViD was obligated to 11 12 provide funding in exchange for product development. The court can ascertain two separate 13 provisions as components of AViD’s “funding obligation,” (1) the obligation to fund $1,500,000 14 and (2) the obligation to “favorably consider” funding overages that may exceed the funding 15 budget of approximately $400,000. The first obligation is not in dispute, as Arixa acknowledges 16 in its amended answer that AViD paid the amount in full. (ECF No. 27 at 19). 17 18 Arixa alleges that AViD halted payments pursuant to the contract and “failed to honor” its 19 funding obligations which caused Arixa financial problems. (ECF No. 27 at 28). At the pleading 20 stage, these allegations are sufficient to support a plausible claim for relief for breach of contract. 21 Whether AViD acted within its contractual rights in using discretion in funding overages is a 22 factual issue not appropriate for resolution on a 12(b)(6) motion. Arixa’s breach of contract claim 23 24 therefore survives dismissal. 25 B. Breach of the Implied Covenant of Good Faith and Fair Dealing. 26 Under Delaware law, every contract contains an implied covenant of good faith and fair 27 dealing. Dunlap v. State Farm Fire & Cas. Co., 878 A.2d 434, 442 (Del. 2005). “To sufficiently 28 1 plead [a] breach of the implied covenant of good faith and fair dealing, a complaint must allege a 2 specific implied contractual obligation, a breach of that obligation by the defendant, and resulting 3 damage to the plaintiff.” Baldwin v. New Wood Res. LLC, 283 A.3d 1099, 1117-1118. The 4 “implied covenant analysis will only be applied when the contract is truly silent with respect to the 5 6 matter at hand, and only when the court finds that the expectations of the parties were so 7 fundamental that it is clear that they did not feel a need to negotiate about them.” Allied Cap. 8 Corp. v. GC-Sun Holdings, L.P., 910 A.2d 1020, 1032-33 (Del. Ch. 2006). 9 Here, Arixa’s implied covenant claim relies on an identical factual basis as its breach of 10 covenant claim. (ECF No. 27 at 27-28). Arixa argues that because AViD’s obligation to 11 12 “favorably consider” additional funding is discretionary, the agreement is effectively silent on how 13 AViD was required to exercise that discretion. (ECF No. 37 at 8). Delaware law is clear that 14 “when a contract confers discretion on one party the implied covenant requires that the discretion 15 be used in good faith.” Airborne Health, Inc. v. Squid Soap, LP, 984 A.2d 126, 146-147 (Del. Ch. 16 2009). 17 18 In Airborne, the court held that it is insufficient for a good faith implied covenant claim to 19 simply allege a failure to confer a benefit, when the defendant had discretion on whether to confer 20 such benefit. Id. at 147. The court dismissed the claim because the plaintiff in Airborne failed to 21 allege any facts indicating that the defendant had exercised its discretion arbitrarily or in bad faith. 22 Id. 23 24 Similarly, here, the countercomplaint does not allege any facts suggesting that AViD failed 25 to exercise its discretion in good faith. Instead, as in Airborne, Arixa merely asserts a failure to 26 confer a benefit that was subject to AViD’s discretion. (ECF No. 27 at 27). Therefore, Arixa’s 27 counterclaim for breach of the implied covenant of good faith and fair dealing is dismissed. 28 1 C. Promissory Estoppel. 2 Under Delaware law, “a claim for promissory estoppel requires a plaintiff to show the 3 following: (i) a promise was made; (ii) it was the reasonable expectation of the promisor to induce 4 action or forbearance on the part of the promisee; (iii) the promisee reasonably relied on the 5 6 promise and took action to his detriment; and (iv) such promise is binding because injustice can 7 be avoided only by enforcement of the promise.” SIGA Techs., Inc. v. PharmAthene, Inc., 67 A.3d 8 330, 347–48 (Del. 2013). 9 “The law of promissory estoppel provides that the promise must be clear, definite and 10 unambiguous and the promise must manifest the promisor's intent to induce the promisee. 11 12 Fridhandler v. Hercules Inc., 2004 WL 7325672, at *2 (Del. Com. Pl. Oct. 29, 2004). Promissory 13 estoppel does not apply, however, where a fully integrated, enforceable contract governs the 14 promise at issue. SIGA, 67 A.3d at 348. 15 Here, Arixa’s promissory estoppel claim relies on two different alleged promises. 16 (ECF No. 27 at 30–31). The first alleged promise is that AViD would pay Arixa’s “employees 17 18 and agents’ time and expense and for amounts paid by Arixa to vendors and other persons or 19 entities providing goods or services for the development project.” Id. at 30. This promise cannot 20 support a claim for promissory estoppel under Delaware law because a fully integrated and 21 enforceable contract governs the same subject matter. SIGA, 67 A.3d at 348. The joint agreement 22 expressly provides that each party is responsible for its own costs and expenses in connection with 23 24 the project. (ECF No. 33, Ex. 1 at 5.) 25 The second alleged promise was that Arixa would receive additional funding if it assisted 26 AViD in securing new investment capital. (ECF No. 27 at 30). This promise appears to fall outside 27 the scope of the written agreement, which is limited to the development and commercialization of 28 1 the products. (ECF No. 33, Ex. 1 at 1). 2 In order to survive dismissal, Arixa must identify the specific promise made by Mr. Baum 3 in soliciting Arixa’s assistance in securing additional investment capital, which it has not. As it 4 stands, the claim fails to allege a clear and definite promise and relies instead on conclusory 5 6 allegations. Cont'l Ins. Co. v. Rutledge & Co., 750 A.2d 1219, 1233 (Del. Ch. 2000). Therefore, 7 the promissory estoppel claim is dismissed. 8 D. Unjust Enrichment. 9 In the state of Nevada, the elements of unjust enrichment are as follows: (1) "benefit 10 conferred on the defendant by the plaintiff; [(2)] appreciation by the defendant of such benefit, 11 12 and; [(3)] acceptance and retention by the defendant of such benefit under circumstances such that 13 it would be inequitable for him to retain the benefit without payment of the value thereof." 14 Leasepartners Corp. v. Robert L. Brooks Trust Dated November 12, 1975, 113 Nev. 747, 755, 942 15 P.2d 182, 187 (1997) (quoting Unionamerica Mortg. & Equity Trust v. McDonald, 97 Nev. 210, 16 211, 626 P.2d 1272 (1981) 17 18 "Unjust enrichment is an action in quasi-contract, [which] cannot lie where a valid express 19 contract covering the same subject matter exists between the parties.” Gerlinger v. Amazon.com, 20 Inc., 311 F.Supp.2d 838, 856 (N.D.Cal. 2004). Thus, the doctrine of unjust enrichment only 21 "applies to situations where there is no legal contract but where the person sought to be charged is 22 in possession of money or property which in good conscience and justice, he should not retain but 23 24 should deliver to another [or should pay for]." Leasepartners, 942 P.2d at 187. 25 Here, Arixa’s unjust enrichment claim is based on the same two distinct factual allegations 26 as the promissory estoppel claim. (ECF No. 27 at 31). The first allegation, that Arixa continued 27 development work without pay, cannot support an unjust enrichment claim under Nevada law 28 1 because that conduct is governed by the express terms of the parties’ written agreement. Where a 2 valid contract governs the subject matter, a claim for unjust enrichment is barred. Leasepartners, 3 942 P.2d at 187. 4 However, the second allegation that Arixa helped AViD secure additional investment 5 6 funding may fall outside the scope of the agreement. The agreement does not appear to address or 7 obligate Arixa to assist in investor relations or fundraising activities. (ECF No. 33, Ex. 1). If Arixa 8 conferred a benefit on AViD in this regard and AViD retained that benefit without compensation, 9 unjust enrichment may be a viable theory. Therefore, the unjust enrichment claim is dismissed 10 with leave to amend, so that Arixa may allege more specific facts regarding the nature of its 11 12 assistance in securing additional funding and the benefit AViD allegedly received from that 13 assistance. 14 E. Punitive Damages 15 “Punitive damages are designed to punish and deter a defendant’s culpable conduct and act 16 as a means for the community to express outrage and distaste for such conduct.” Countrywide 17 18 Home Loans, Inc. v. Thitchener, 124 Nev. 725, 739, 192 P.3d 243, 252 (2008). In an action for 19 breach of an obligation not arising from contract, punitive damages may be awarded upon clear 20 and convincing evidence that the defendant acted with oppression, fraud, or malice. NRS 21 42.005(1). 22 Arixa attempts to rely on Ponsock to invoke an exception to the general rule barring 23 24 punitive damages for contract-based claims. K Mart Corp. v. Ponsock, 103 Nev. 39, 52, 732 P.2d 25 1364, 1373 (1987). In Ponsock, the court held that K Mart’s conduct “could well have been 26 construed as willfully defamatory acts,” finding that the facts underlying the implied covenant of 27 good faith claim supported an independent tortious act sufficient to sustain a jury’s finding of 28 1 malice and oppression. Id. 2 The countercomplaint fails to allege facts identifying any tortious conduct that would 3 satisfy the narrow exception permitting punitive damages in contract-based actions. Failing to 4 provide additional funding beyond an express contractual obligation does not constitute conduct 5 6 that “reeks of oppression or malice.” Id. Therefore, Arixa’s request for punitive damages must be 7 dismissed. 8 IV. CONCLUSION 9 Accordingly, 10 IT IS HEREBY ORDERED, ADJUDGED, and DECREED that AViD’s motion to dismiss 11 12 (ECF No. 33) be, and the same hereby is, GRANTED in part. Arixa’s counterclaims for breach 13 of the implied covenant of good faith and fair dealing, promissory estoppel, unjust enrichment, 14 and it’s request for punitive damages are dismissed without prejudice. 15 IT IS FURTHER ORDERED that Arixa may file an amended countercomplaint within 21 16 days of this order. Failure to do so will result in dismissal of its counterclaims with prejudice. 17 18 DATED July 17, 2025. 19 20 ______________________________________ UNITED STATES DISTRICT JUDGE 21
23 24 25 26 27 28